​

MetLife (MET) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MET Stock Forecast

MetLife (MET) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $101.50, with a high of $109.00 and a low of $94.00. This represents a 41.56% increase from the last price of $71.70.

$65 $74 $83 $92 $101 $110 High: $109 Avg: $101.5 Low: $94 Last Closed Price: $71.7

MET Stock Rating

MetLife stock's rating consensus is Buy, based on 31 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (83.87%), 5 Hold (16.13%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 31 0 5 26 Strong Sell Sell Hold Buy Strong Buy

MET Price Target Upside V Benchmarks

TypeNameUpside
StockMetLife41.56%
SectorFinancial Services Stocks 14.04%
IndustryLife Insurance Stocks 10.03%

Price Target Trends

1M3M12M
# Anlaysts128
Avg Price Target$94.00$101.50$90.88
Last Closing Price$71.70$71.70$71.70
Upside/Downside31.10%41.56%26.75%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25573-116
Mar, 25573-116
Feb, 25573-116
Jan, 25573-116
Dec, 24572-115
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 02, 2025John BarnidgePiper Sandler$94.00$82.4913.95%31.10%
Feb 28, 2025Morgan Stanley$109.00$86.1826.48%52.02%
Oct 02, 2024John BarnidgePiper Sandler$92.00$81.7812.50%28.31%
Sep 04, 2024Alex ScottBarclays$91.00$77.5217.39%26.92%
Aug 01, 2024Joshua ShankerBank of America Securities$96.00$76.8524.92%33.89%
Jul 10, 2024Bob HuangMorgan Stanley$83.00$69.9218.71%15.76%
May 22, 2024Kevin HealArgus Research$80.00$73.159.36%11.58%
May 06, 2024John BarnidgePiper Sandler$82.00$70.9415.59%14.37%
Mar 13, 2024Catherine SeifertCFRA$77.00$72.675.96%7.39%
Jan 08, 2024Alex ScottGoldman Sachs$80.00$68.9216.08%11.58%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 02, 2025Piper SandlerOverweightOverweighthold
Mar 07, 2025Cowen & Co.BuyBuyhold
Jan 22, 2025BMO CapitalMarket Performinitialise
Oct 08, 2024Cowen & Co.Buyinitialise
Oct 02, 2024Piper SandlerOverweightOverweighthold
Sep 27, 2024JefferiesBuyBuyhold
Sep 26, 2024Evercore ISIOutperformOutperformhold
Aug 12, 2024Wells FargoOverweightOverweighthold
Jul 23, 2024CitigroupBuyBuyhold
Jul 18, 2024JefferiesBuyBuyhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.72$7.36$2.93$1.81$6.33---
Avg Forecast$5.68$8.47$6.95$7.31$8.21$9.61$10.74$11.96
High Forecast$5.92$8.83$7.23$7.44$8.33$9.86$11.56$13.81
Low Forecast$5.45$8.14$6.70$7.11$8.02$9.36$8.49$8.58
Surprise %0.70%-13.11%-57.84%-75.24%-22.90%---

Revenue Forecast

$60B $65B $70B $75B $80B $85B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$67.84B$71.08B$69.90B$66.41B$70.99B---
Avg Forecast$62.06B$67.68B$77.30B$71.42B$72.81B$76.54B$79.69B$83.81B
High Forecast$64.08B$69.88B$79.77B$72.37B$74.27B$79.27B$79.73B$83.81B
Low Forecast$60.18B$65.63B$75.22B$70.70B$71.50B$74.72B$79.64B$83.81B
Surprise %9.31%5.02%-9.58%-7.01%-2.51%---

Net Income Forecast

$1B $3B $5B $7B $9B $11B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.41B$6.86B$2.35B$1.58B$4.43B---
Avg Forecast$4.89B$3.87B$2.40B$1.38B$6.23B$7.33B$7.64B$6.60B
High Forecast$5.86B$4.64B$2.88B$1.66B$6.35B$7.52B$8.81B$10.52B
Low Forecast$3.91B$3.10B$1.92B$1.10B$6.12B$7.14B$6.47B$6.54B
Surprise %10.68%77.11%-1.76%14.35%-28.98%---

MET Forecast FAQ

Is MetLife stock a buy?

MetLife stock has a consensus rating of Buy, based on 31 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MetLife is a favorable investment for most analysts.

What is MetLife's price target?

MetLife's price target, set by 31 Wall Street analysts, averages $101.5 over the next 12 months. The price target range spans from $94 at the low end to $109 at the high end, suggesting a potential 41.56% change from the previous closing price of $71.7.

How does MetLife stock forecast compare to its benchmarks?

MetLife's stock forecast shows a 41.56% upside, outperforming the average forecast for the financial services stocks sector (14.04%) and outperforming the life insurance stocks industry (10.03%).

What is the breakdown of analyst ratings for MetLife over the past three months?

  • April 2025: 31.25% Strong Buy, 43.75% Buy, 18.75% Hold, 0% Sell, 6.25% Strong Sell.
  • March 2025: 31.25% Strong Buy, 43.75% Buy, 18.75% Hold, 0% Sell, 6.25% Strong Sell.
  • February 2025: 31.25% Strong Buy, 43.75% Buy, 18.75% Hold, 0% Sell, 6.25% Strong Sell.

What is MetLife’s EPS forecast?

MetLife's average annual EPS forecast for its fiscal year ending in December 2025 is $9.61, marking a 51.82% increase from the reported $6.33 in 2024. Estimates for the following years are $10.74 in 2026, and $11.96 in 2027.

What is MetLife’s revenue forecast?

MetLife's average annual revenue forecast for its fiscal year ending in December 2025 is $76.54B, reflecting a 7.83% increase from the reported $70.99B in 2024. The forecast for 2026 is $79.69B, and $83.81B for 2027.

What is MetLife’s net income forecast?

MetLife's net income forecast for the fiscal year ending in December 2025 stands at $7.33B, representing an 65.58% increase from the reported $4.43B in 2024. Projections indicate $7.64B in 2026, and $6.6B in 2027.